Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that regulate epithelial-mesenchymal transition.

Epithelial-mesenchymal transition (EMT) is a key event in the generation of invasive tumor cells. A hallmark of EMT is the repression of E-cadherin expression, which is regulated by various signal transduction pathways including extracellular signal-regulated kinase (ERK) and Wnt. These pathways are highly interconnected via multiple coupled feedback loops (CFL). As the function of such coupled feedback regulations is difficult to analyze experimentally, we used a systems biology approach where computational models were designed to predict biological effects that result from the complex interplay of CFLs. Using epidermal growth factor (EGF) and Wnt as input and E-cadherin transcriptional regulation as output, we established an ordinary differential equation model of the ERK and Wnt signaling network containing six feedback links and used extensive computer simulations to analyze the effects of these feedback links in isolation and different combinations. The results show that the feedbacks can generate a rich dynamic behavior leading to various dose-response patterns and have a decisive role in determining network responses to EGF and Wnt. In particular, we made two important findings: first, that coupled positive feedback loops composed of phosphorylation of Raf kinase inhibitor RKIP by ERK and transcriptional repression of RKIP by Snail have an essential role in causing a switch-like behavior of E-cadherin expression; and second, that RKIP expression inhibits EMT progression by preventing E-cadherin suppression. Taken together, our findings provide us with a system-level understanding of how RKIP can regulate EMT progression and may explain why RKIP is downregulated in so many metastatic cancer cells.

[1]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[2]  Kwang-Hyun Cho,et al.  Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway , 2009, Journal of Cell Science.

[3]  W. Kolch,et al.  Snail is a repressor of RKIP transcription in metastatic prostate cancer cells , 2008, Oncogene.

[4]  M. Rosner,et al.  Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor , 2008, Cell Research.

[5]  W. Kolch,et al.  Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability , 2008, Journal of Clinical Pathology.

[6]  A. Adjei,et al.  Advances in Targeting the Ras/Raf/MEK/Erk Mitogen-Activated Protein Kinase Cascade with MEK Inhibitors for Cancer Therapy , 2008, Clinical Cancer Research.

[7]  M. Taketo,et al.  Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene , 2007, Journal of Cell Science.

[8]  C. Heldin,et al.  Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.

[9]  M. Mimeault,et al.  Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  D. Kim,et al.  A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK Pathways , 2007, Oncogene.

[11]  B. Rubino,et al.  The role of epithelial-mesenchymal transition in cancer pathology. , 2007, Pathology.

[12]  O. Rath,et al.  MAP kinase signalling pathways in cancer , 2007, Oncogene.

[13]  Y. Surh,et al.  Axin Inhibits Extracellular Signal-regulated Kinase Pathway by Ras Degradation via β-Catenin* , 2007, Journal of Biological Chemistry.

[14]  J. Jass,et al.  Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. , 2007, American journal of clinical pathology.

[15]  W. Kolch,et al.  Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Raghu Kalluri,et al.  The epithelial–mesenchymal transition: new insights in signaling, development, and disease , 2006, The Journal of cell biology.

[17]  Y. Surh,et al.  APC inhibits ERK pathway activation and cellular proliferation induced by RAS , 2006, Journal of Cell Science.

[18]  Y. Zhou,et al.  Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase , 2006, Oncogene.

[19]  M. Almeida,et al.  Wnt Proteins Prevent Apoptosis of Both Uncommitted Osteoblast Progenitors and Differentiated Osteoblasts by β-Catenin-dependent and -independent Signaling Cascades Involving Src/ERK and Phosphatidylinositol 3-Kinase/AKT* , 2005, Journal of Biological Chemistry.

[20]  Karin Oien,et al.  Reduction of Raf-1 Kinase Inhibitor Protein Expression Correlates with Breast Cancer Metastasis , 2005, Clinical Cancer Research.

[21]  Jun Qin,et al.  Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin , 2005 .

[22]  E. Keller,et al.  The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein , 2005, Journal of cellular biochemistry.

[23]  M. Hung,et al.  Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition , 2004, Nature Cell Biology.

[24]  A. Asthagiri,et al.  Epidermal Growth Factor-mediated T-cell Factor/Lymphoid Enhancer Factor Transcriptional Activity Is Essential but Not Sufficient for Cell Cycle Progression in Nontransformed Mammary Epithelial Cells* , 2004, Journal of Biological Chemistry.

[25]  K. Yeung,et al.  Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene. , 2004, Cancer letters.

[26]  Reinhart Heinrich,et al.  The Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt Pathway , 2003, PLoS biology.

[27]  M. Rubin,et al.  Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis , 2003 .

[28]  K. Wolff,et al.  Fibroblast Growth Factor-2 Induces Lef/Tcf-dependent Transcription in Human Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[29]  Kathleen R. Cho,et al.  Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. , 2002, The Journal of biological chemistry.

[30]  Kathleen R. Cho,et al.  Activation of AXIN2 Expression by β-Catenin-T Cell Factor , 2002, The Journal of Biological Chemistry.

[31]  J. Thiery Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[32]  Choun-Ki Joo,et al.  Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway , 2002, Molecular and Cellular Biology.

[33]  R. Knuechel,et al.  Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  F. Bertrand,et al.  Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation , 2001, Oncogene.

[35]  I. Beavon The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. , 2000, European journal of cancer.

[36]  W. Kolch,et al.  Mechanism of Suppression of the Raf/MEK/Extracellular Signal-Regulated Kinase Pathway by the Raf Kinase Inhibitor Protein , 2000, Molecular and Cellular Biology.

[37]  W. Kolch,et al.  Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP , 1999, Nature.

[38]  J. Pessin,et al.  SOS Phosphorylation and Disassociation of the Grb2-SOS Complex by the ERK and JNK Signaling Pathways (*) , 1996, The Journal of Biological Chemistry.

[39]  S. Paul,et al.  Wnt signaling and cancer development: therapeutic implication. , 2008, Neoplasma.

[40]  Jun Qin,et al.  Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. , 2005, Molecular cell.

[41]  Hans Clevers,et al.  The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. , 2002, Cell.

[42]  F. Bertrand,et al.  Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. , 2001, Oncogene.

[43]  Ronald J. Tocci,et al.  Digital Systems: Principles and Applications , 1977 .